Search

BOSTON (February 22, 2023) – Saul Ewing LLP today announced that Partner Joseph D. Lipchitz has been named Managing Partner of the firm’s Boston office. The Managing Partner is responsible for the office’s budget, internal communications and events, in addition to overseeing the firm’s involvement...

Neither shots nor pills will immunize smaller medical, dental, chiropractic, and physical therapy practices, surgery centers, and other healthcare concerns from compliance with the looming (and burdensome) reporting obligations imposed on them if they are “reporting companies” under the federal...

​Final regulations published on September 30, 2022 (the “final Regulations”) by the Financial Crimes Enforcement Network (“FinCEN”) of the Department of Treasury under the Corporate Transparency Act (“CTA”) grant business owners a reprieve, but not a pardon, with respect to their looming beneficial...

The use of artificial intelligence (AI) to create works of art and inventions raises interesting legal challenges to the protection of intellectual property (IP). The plain language of the Copyright Act and Patent Act present obstacles to inventors and artists who may use or be AI systems. Recent...

Gary Lipkin brings more than two decades of legal experience to his new role as a partner in Saul Ewing’s Litigation Department, including handling a diverse range of cases before the nation’s preeminent business court, the Delaware Court of Chancery. He resides in the Firm’s Wilmington office. Mr...

Steven Reingold, a Partner in the firm's Litigation Practice, will participate as a speaker during the Newbie Litigator webinar, hosted by Financial Poise. This webinar discusses procedures and strategies for obtaining temporary restraining orders and preliminary injunctions. The topics discussed...

PRE-LITIGATION BOOTCAMP FOR IN-HOUSE PRACTITIONERS Michael Joyce, a Partner in the Firm's Commercial Litigation practice, will participate as a panelist during an Association of Corporate Counsel webinar. This webinar will cover steps that in-house lawyers can take to minimize and, if necessary...

THE CLASS ACTION MECHANISM, RISKS, AND STRATEGIES TO PROTECT YOUR COMPANY Jon Singer, a Partner in the Firm's Class Actions Practice, will be speaking during the Association of Corporate Counsel's July New to In-House Update. This session will provide a high level overview intended to educate new in...

Veronica McCarty is a litigator who represents inventors and companies in intellectual property disputes, particularly for inventions involving computing and biopharmaceutical technologies, as well as medical devices. Veronica works on patent trials, including on ANDA bench trials, and she assists...

Industry-Specific, Business-Focused Legal Advice Increased pricing pressure combined with a rise in generic competition and continued regulatory uncertainty have squeezed the margins of life sciences companies. Helping navigate this ever-shifting terrain, Saul Ewing’s Life Sciences Practice consists...

David Berk counsels families and their businesses, entrepreneurs and start-up companies in taxation, structuring transactions, contract negotiations and governance issues. David also advises clients on corporate succession planning, trust and estate planning, insurance and retirement planning and...

Marshall Paul focuses his practice on counseling businesses, health care concerns and professionals with respect to limited liability company matters, general corporate matters, joint ventures, acquisitions and sales, fiduciary duty issues and financings. His clients include large-scale health care...

Eric Orlinsky co-chairs the firm's Corporate Practice and its Private Equity/Venture Capital subgroup and concentrates his practice in general business and securities law and counsels clients in private equity and venture capital investments, public and private offerings of debt and equity...

Barry F. Levin provides high-level legal counsel on complex corporate and real estate transactions that shape the future of businesses across a wide variety of industries. His keen understanding of how legal issues intersect with business interests in these deals and other corporate matters stems...

Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...